Electroacupuncture improves recovery after hemorrhagic brain injury by inducing the expression of angiopoietin-1 and -2 in rats
© Zhou et al.; licensee BioMed Central Ltd. 2014
Received: 1 September 2013
Accepted: 31 March 2014
Published: 5 April 2014
Angiopoietin (Ang) is one of the major effectors of angiogenesis, playing a critical role in neurovascular remodeling after stroke. Acupuncture has been widely used for treating stroke in China for a long time. Recently, we have demonstrated that electroacupuncture (EA) can accelerate intracerebral hemorrhage (ICH)-induced angiogenesis in rats. In the present study, we investigated the effect of EA on the expression of Ang-1 and Ang-2 in the brain after ICH.
ICH was induced by stereotactic injection of collagenase type VII into the right globus pallidus. Adult male Sprague–Dawley rats were randomized into the following four groups: sham-operation (SHAM), stroke-no electroacupuncture (SNE), stroke-EA at the Zusanli acupoint (SEZ), and stroke-EA at a nonacupoint (SEN). EA was applied to the bilateral Zusanli (ST36) acupoint in the SEZ group and a nonacupoint in the SEN group. The expression of Ang-1 and Ang-2 was evaluated by immunohistochemistry and quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR).
Some Ang-1 and Ang-2 immunoreactive microvessels with a dilated outline were detected in the perihematomal tissues after ICH, and the vessels extended into the clot from the surrounding area since day 7. The expression of Ang-1 increased notably as long as 2 weeks after ICH, while Ang-2 immunoreactivity declined at about 7 days following a striking upregulation at 3 days. EA at the Zusanli (ST36) acupoint upregulated the expression of Ang-1 and Ang-2 at both the protein and mRNA levels. However, EA at a nonacupoint had little effect on the expression of Ang-1 and Ang-2.
Our data suggest that EA at the Zusanli (ST36) acupoint exerts neuroprotective effects on hemorrhagic stroke by upregulation of Ang-1 and Ang-2.
KeywordsElectroacupuncture Zusanli acupoint Intracerebral hemorrhage Angiogenesis Angiopoietin
Intracerebral hemorrhage (ICH) is a lethal stroke type, as mortality approaches 50% and neurological disability in survivors is common . Despite decades of intense research, current treatments for minimizing disability and mortality after ICH are far from satisfactory.
Angiogenesis, the outgrowth of new vessels from pre-existing vasculature, may play a critical role in neurovascular remodeling, which is a key component of recovery after stroke . Furthermore, it is currently considered that angiogenesis promotes neurogenesis  and that regrowth of vascular structures might provide the requisite molecular (as well as anatomic) support for recovering neural networks .
The angiopoietin family, including Ang-1 and Ang-2, is one of the major effectors of angiogenesis. These molecules carry out signaling through the receptor tyrosine kinase Tie-2. Ang-1 is expressed on endothelial cells  and has been shown to promote the stabilization, maturation, and remodeling of vascular networks in the brain . In contrast, Ang-2 is thought to destabilize vascular networks by inhibiting the Ang-1/Tie-2 interaction .
Electroacupuncture (EA) is a traditional therapy that has been widely applied for the treatment of hemorrhagic stroke because it has been shown to improve the outcome in experimental animals [8, 9] and clinical practice . Our previous studies have demonstrated that angiogenesis can occur in rat brains with ICH [11–13]. Moreover, we have recently demonstrated that EA can accelerate ICH-induced angiogenesis in rats and upregulate the expression of hypoxia-inducible factor-1α . However, to date, there have been few reports regarding the effect of EA on the expression of Ang-1 and Ang-2 after ICH. In the present study, we investigated whether EA at the Zusanli (ST36) acupoint improves recovery after ICH by enhancing the expression of Ang-1 and Ang-2 in rats, thereby elucidating the mechanism of EA to enhance ICH-induced angiogenesis and providing new evidence for the application of acupuncture for the treatment of ICH.
Studies were carried out on adult male Sprague–Dawley rats (250–300 g, 8–10 weeks of age) obtained from the Experimental Animal Science Center of Central South University, which were housed under identical conditions (room temperature at 25°C, 12 h light–dark cycle) and allowed free access to food and water. The experiment was performed in compliance with the guidelines of Central South University and the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 80–23); and the protocol was approved by the Institutional Animal Care and Use Committee of Central South University (2008-xy-0116). Rats with collagenase-induced ICH were randomly divided into four groups (n = 30 in each group): sham-operation group (SHAM), stroke-no EA (SNE), stroke-EA at the Zusanli acupoint (SEZ), and stroke-EA at a nonacupoint (SEN).
Induction of intracerebral hemorrhage
ICH was induced with collagenase according to a previous protocol . After anesthetization with chloral hydrate (400 mg/kg) via intraperitoneal injection, the animals were fixed in the prone position on a stereotactic frame (Stoelting Co., USA). Following a scalp incision, a small cranial burr was drilled near the right coronal suture at 3.2 mm lateral to the midline. Bacterial type VII collagenase (0.5 U in 2.5 μL of 0.9% sterile saline, Sigma Co., USA) was slowly injected into the right globus pallidus (1.4 mm posterior and 3.2 mm lateral to the bregma, 5.6 mm ventral to the cortical surface) with a 5-μL Hamilton syringe for at least 5 min, and the needle remained there for another 5 min. The bone hole was sealed with bone wax, and then the wound was sutured. The animals were placed in a warm box to recover individually. For the SHAM group, the rats were injected with 2.5 μL of 0.9% sterile saline without collagenase at the same site. During the procedure, the rectum temperature was monitored and maintained at 37.5°C with a feedback-controlled heating pad.
The rats were placed into tailor-made mouse cages, and their bilateral legs were sufficiently exposed. Stainless acupuncture needles of 0.3 mm in diameter were bilaterally inserted at a depth of about 2–4 mm into the locus of the Zusanli (ST36) acupoint, which was located at 5 mm lateral and distal to the anterior tubercle of the tibia in the SEZ group. The needles were inserted into the hip in the SEN group. The rats were acupunctured with an electrical needle stimulator (WQ1002K, Electro-Acupuncture Equipment Company, China) at 9–10 am, 30 min each time for 14 days. The frequency was 2–20 Hz. The original intensity was 2 V and was increased by 1 V every 10 min. All rats were conscious when EA was performed. No stimulation was given to the SNE and SHAM groups.
According to the study reported by Hua et al. , the use of a forelimb asymmetry test was adopted. Every rat was laid in a transparent cylinder, 20 cm in diameter and 30 cm in height. A mirror was placed near the cylinder at an angle convenient for observing the forelimb movement of the rat; and at the same time, simultaneous recording was performed by a video camera. The test lasted 10 min. In the testing time, the rat behavior was quantified by counting the occasions that the rat's forelimb touched the cylinder wall while it was in an orthostatic position with a balanced gravity center: the occasions of contact with the unimpaired (ipsilateral) forelimb were recorded as I, that with the impaired forelimb (contralateral to the collagenase injection site) as C, and with both forelimbs as B. Then, the forelimb asymmetric use rate (AUR) was calculated by the following formula: AUR = [I/(I + C + B)] - [C/(I + C + B)].
Under deep anesthesia with chloral hydrate (800 mg/kg), the collagenase-induced ICH animals (n = 5, per time point) were randomly chosen at day 3, day 7, and day 14 postoperation, and they were transcardially perfused with 0.9% saline followed by 250 mL of ice-cold 4% paraformaldehyde in 0.1 M phosphate buffer (pH = 7.4). The brains were removed and post-fixed in the same fixative for 2 h, and then sequentially transferred to 20% and 30% sucrose in 0.1 M phosphate buffer (pH = 7.4) at 4°C until sinking. The brains were cut for 30-μm coronal sections at -20°C with a cryostat (CM1900, Leica Co., Germany) for immunohistochemical staining.
Sections were brought to room temperature and incubated in 3% H2O2 in methanol for 15 min. After washing three times in phosphate-buffered saline for 5 min each, nonspecific binding was blocked in 5% bovine serum albumin (BSA, Sigma, USA) for 1 h at 37°C. Sections were not washed, incubated with goat anti-Ang-1 (Santa Cruz Biotech, 1:100) or goat anti-Ang-2 (Santa Cruz Biotech, 1:100) overnight at 4°C, then with a biotinylated anti-goat IgG (1:100) for 1 h. Color development was performed with a Vectastain ABC kit (Vector Laboratories), according to the vendor’s protocol. As a negative control, 1% BSA was used instead of the primary antibody. The mean optical densities (MODs) of HIF-1α-, VEGF-, Ang-1-, and Ang-2-positive microvessels were measured quantitatively within the striatum adjacent to the hematoma with the Motic Images Advance 3.2 image analysis system.
Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was purified from 100 mg of tissue near the hematoma in each group using the TRIZOL Reagent (Invitrogen, Carlsbad, CA). The integrity of the total RNA was detected by agarose gel electrophoresis; the purity and concentration were detected by a spectrophotometer (UV-1201, Shimadzu). Reverse transcription was performed with 2 μg of total RNA using 1 μg/μL oligo(dT)18 (1 μL), 10 mM dNTP Mix (2 μL), RNase inhibitor (1 μL), and 200 U/μL M-Mulv-Reverse Transcriptase (1 μL) at 70°C for 5 min, 37°C for 5 min, 42°C for 60 min, and 70°C for 10 min, following the manufacturer’s instructions (Fermentas, CA). The cDNA was stored at -20°C. PCR amplification was performed using a SYBR Premix ExTaq™ PCR kit (4 μL of 1:2 cDNA dilution was used, Takara Biotechnology, Japan) in a LightCycler Real-Time Detection System (Roche Diagnostics Limited, Germany). The following thermocycling protocol was used: 10 s at 95°C; 30–40 cycles of 5 s at 95°C, 20 s at 52°C, and 10 s at 72°C; and a melting curve at 60°C. Primers for Ang-1, Ang-2, and β-actin were designed with Primer Premier 5.0 software for the rat (PRIMER Biosoft International, CA) as follows: Ang-1, sense 5′- CACCGTGAGGATGGAAGCCTA-3′ and antisense 5′- TTCCCAAGCCAATATTCACCAGA-3′; Ang-2, sense 5′- CAGTAGCATCAGCCAACCAGGA-3′ and antisense 5′- GACCACATGCGTCGAACCAC-3′; β-actin, sense 5′- CGTTGACATCCGTAAAGAC-3′ and antisense 5′- TGGAAGGTGGACAGTGAG-3′. Melting curves of all samples were performed as controls of specificity. All gene expression data were calculated as 2-ΔΔCT (n = 5), which indicates an n-fold change in gene expression relative to the SHAM control sample .
All data in this study are presented as mean ± standard deviation (SD). Data were analyzed by the Student’s t-test and one-way analysis of variance, followed by Scheffe’s post-hoc test. Differences were considered significant at P < 0.05.
Overexpression of Ang-1 and Ang-2 after EA
Ang-1 immunoreactivity increased notably as long as 2 weeks after ICH (P < 0.01), while Ang-2 immunoreactivity declined at about 7 days following a striking upregulation at 3 days (P < 0.05). EA at the Zusanli (ST36) acupoint increased Ang-1 expression notably from 3 days to 14 days and Ang-2 expression only at 3 days as compared with no EA treatment after ICH (P < 0.05). Meanwhile, there was no significant difference in the expression of Ang-1 and Ang-2 between the SEN group and the SNE group (Figure 2C and D).
Increased mRNA Expression of Ang-1 and Ang-2 after EA
The present study demonstrated that EA can exert neuroprotective effects directly against hemorrhagic injury in rats. ICH upregulated the expression of Ang-1 and Ang-2, and EA further increased their expression.
It is well known that angiogenic factors play an essential role in regulating angiogenesis. Previous studies have demonstrated that angiogenesis in the brain occurs normally during early development  and can occur under pathological conditions such as ischemia [19, 20] or hemorrhage [11–13]. Along with the development of neurovascularization, the role of angiogenesis in the recovery of stroke has received increasing attention in recent years. Ang-1 and Ang-2 have been shown to take part in regulating ischemia-induced angiogenesis in rat brains [19, 20].
Numerous studies have demonstrated that acupuncture at the Zusanli (ST36) acupoint possesses a neuroprotective effect by suppressing neuron apoptosis [21, 22], improving neural plasticity , increasing cerebral blood flow, and improving microcirculation  in ischemic rat brains. Recently, acupuncture at the Zusanli acupoint has been shown to not only suppress ICH-induced apoptotic neuronal cell death  but also accelerate ICH-induced angiogenesis in rats .
The present study showed a remarkable increase in the expression of Ang-1 and Ang-2 after ICH. These changes come not only from the induction of ICH, but, more significantly, from EA at the Zusanli acupoint. A robust upregulation of Ang-2 at the earliest stages of ICH caused by EA may destabilize the vessel and promote disassembly of the cellular components, allowing the formation of new vessels to occur in the endothelium [25, 26]. In addition, the upregulation of Ang-1 resulting from EA might reflect an initial attempt to protect the peripheral vasculature from leakage at the early stage  and promote the stabilization and maturation of new vessels at the late stage .
It is common knowledge that ICH can cause increases of many inflammatory factors such as tumor necrosis factor-α and interleukin  as well as induce excessive nitric oxide (NO) production . Several studies have shown that NO can upregulate Ang-1 expression after stroke, and the effects of inflammatory cytokines on the expression of Ang-1 and Ang-2 depend on their concentration: high concentrations of cytokines result in negative expression of Ang-1 and Ang-2, while low concentrations of cytokines result in positive expression of Ang-1 and Ang-2 [30–33]. Furthermore, EA can upregulate the NO level  and have an anti-inflammatory effect after stroke . Accordingly, it is tempting to suppose that EA at the Zusanli (ST36) acupoint regulates the expression of Ang-1 and Ang-2 by increasing the NO level and decreasing inflammation. ICH also leads to upregulation of endothelial nitric oxide synthase (eNOS) , which is responsible for the angiogenic action of Ang-1 . Moreover, EA can upregulate the eNOS level . Hence, the upregulation of Ang-1 induced by EA after ICH may exert its angiogenic action through eNOS.
Angiogenesis is a complex process that requires orchestrated effects of many growth factors. Other than the Ang family, there are many pro-angiogenic (e.g., fibroblast growth factor, transforming growth factor) and anti-angiogenic (e.g., endostatin, thrombospondin) growth factors . Thus, EA-induced neuroprotection in hemorrhagic stroke probably also involves these mechanisms. However, further studies are needed to provide direct evidence showing the causal relationship between EA-induced motor improvement and cellular expression of angiogenesis. In addition, understanding how this effect is regulated in vivo by the interaction with other growth factors is a continuing challenge.
In summary, EA in rats subjected to ICH improves neurological recovery, which may be associated with angiogenesis and the expression of angiogenic factors. Moreover, the upregulation of Ang-1 and Ang-2 triggered by EA may act as one of the mechanisms of EA-induced neuroprotection in stroke.
Endothelial nitric oxide synthase
This study was supported by grants from the National Natural Science Foundation of China (Grant Nos. 30400581, 30873221, 81173175, and 81202625), the Project for New Century Excellent Talents (NCET-11-0522), and the Hunan Provincial Natural Science Foundation (Grant Nos. 07JJ5007 and 10JJ2023).
- Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF: Spontaneous intracerebral hemorrhage. N Engl J Med. 2001, 344 (19): 1450-1460. 10.1056/NEJM200105103441907.View ArticlePubMedGoogle Scholar
- Arai K, Jin G, Navaratna D, Lo EH: Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke. FEBS J. 2009, 276 (17): 4644-4652. 10.1111/j.1742-4658.2009.07176.x.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang RL, Zhang ZG, Chopp M: Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy. Neuroscientist. 2005, 11 (5): 408-416. 10.1177/1073858405278865.View ArticlePubMedGoogle Scholar
- Ohab JJ, Fleming S, Blesch A, Carmichael ST: A neurovascular niche for neurogenesis after stroke. J Neurosci. 2006, 26 (50): 13007-13016. 10.1523/JNEUROSCI.4323-06.2006.View ArticlePubMedGoogle Scholar
- Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Gene dev. 1994, 8 (16): 1897-1909. 10.1101/gad.8.16.1897.View ArticlePubMedGoogle Scholar
- Ward NL, Lamanna JC: The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol Res. 2004, 26 (8): 870-883. 10.1179/016164104X3798.View ArticlePubMedGoogle Scholar
- Karamysheva AF: Mechanisms of angiogenesis. Biochemistry. 2008, 73 (7): 751-762.PubMedGoogle Scholar
- Cho NH, Lee JD, Cheong BS, Choi DY, Chang HK, Lee TH, Shin MC, Shin MS, Lee J, Kim CJ: Acupuncture suppresses intrastriatal hemorrhage-induced apoptotic neuronal cell death in rats. Neurosci Lett. 2004, 362 (2): 141-145. 10.1016/j.neulet.2004.03.027.View ArticlePubMedGoogle Scholar
- Yang YJ, Kim YS, Shin MS, Chang HK, Lee TH, Sim YJ, Shin MC, Park HY, Kim S, Park HK: Effects of acupuncture on the intrastriatal hemorrhage-induced caspase3 expression and newly cell birth in rats. Neurol Res. 2007, 29 (Suppl 1): S65-S71.View ArticlePubMedGoogle Scholar
- Ko CN, Lee IW, Cho SY, Lee SH, Park SU, Koh JS, Park JM, Kim GK, Bae HS: Acupuncture for cerebral vasospasm after subarachnoid hemorrhage: a retrospective case–control study. J Altern Complement Med. 2013, 19 (5): 471-473. 10.1089/acm.2012.0076.View ArticlePubMedGoogle Scholar
- Tang T, Liu XJ, Zhang ZQ, Zhou HJ, Luo JK, Huang JF, Yang QD, Li XQ: Cerebral angiogenesis after collagenase-induced intracerebral hemorrhage in rats. Brain Res. 2007, 1175: 134-142.View ArticlePubMedGoogle Scholar
- Zhou H, Tang T, Guo C, Zhang H, Zhong J, Zheng J, Luo J, Lin Y, Liu W, Luo W, Yang Q: Expression of Angiopoietin-1 and the receptor Tie-2 mRNA in rat brains following intracerebral hemorrhage. Acta Neurobiol Exp. 2008, 68 (2): 147-154.Google Scholar
- Zhou HJ, Zhang HN, Tang T, Zhong JH, Qi Y, Luo JK, Lin Y, Yang QD, Li XQ: Alteration of thrombospondin-1 and -2 in rat brains following experimental intracerebral hemorrhage. J Neurosurg. 2010, 113 (4): 820-825. 10.3171/2010.1.JNS09637.View ArticlePubMedGoogle Scholar
- Luo JK, Zhou HJ, Wu J, Tang T, Liang QH: Electroacupuncture at Zusanli (ST36) accelerates intracerebral hemorrhage-induced angiogenesis in rats. Chin J Integr Med. 2013, 19 (5): 367-373. 10.1007/s11655-013-1458-y.View ArticlePubMedGoogle Scholar
- Rosenberg GA, Mun-Bryce S, Wesley M, Kornfeld M: Collagenase-induced intracerebral hemorrhage in rats. Stroke. 1990, 21 (5): 801-807. 10.1161/01.STR.21.5.801.View ArticlePubMedGoogle Scholar
- Hua Y, Schallert T, Keep RF, Wu J, Hoff JT, Xi G: Behavioral tests after intracerebral hemorrhage in the rat. Stroke. 2002, 33 (10): 2478-2484. 10.1161/01.STR.0000032302.91894.0F.View ArticlePubMedGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
- Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR: Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. 2000, 119 (1): 139-153. 10.1016/S0165-3806(99)00125-X.View ArticleGoogle Scholar
- Zhang Z, Chopp M: Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Cardiovasc Med. 2002, 12 (2): 62-66. 10.1016/S1050-1738(01)00149-9.View ArticlePubMedGoogle Scholar
- Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M: Correlation of VEGF and angiopoietin expression with disruption of blood–brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002, 22 (4): 379-392.View ArticlePubMedGoogle Scholar
- Wang SJ, Omori N, Li F, Jin G, Zhang WR, Hamakawa Y, Sato K, Nagano I, Shoji M, Abe K: Potentiation of Akt and suppression of caspase-9 activations by electroacupuncture after transient middle cerebral artery occlusion in rats. Neurosci Lett. 2002, 331 (2): 115-118. 10.1016/S0304-3940(02)00866-2.View ArticlePubMedGoogle Scholar
- Wang T, Liu CZ, Yu JC, Jiang W, Han JX: Acupuncture protected cerebral multi-infarction rats from memory impairment by regulating the expression of apoptosis related genes Bcl-2 and Bax in hippocampus. Physiol Behav. 2009, 96 (1): 155-161. 10.1016/j.physbeh.2008.09.024.View ArticlePubMedGoogle Scholar
- Ren L, Zhang WA, Fang NY, Wang JX: The influence of electro-acupuncture on neural plasticity in acute cerebral infarction. Neurol Res. 2008, 30 (9): 985-989. 10.1179/174313208X325182.View ArticlePubMedGoogle Scholar
- Hsieh CL, Chang QY, Lin IH, Lin JG, Liu CH, Tang NY, Lane HY: The study of electroacupuncture on cerebral blood flow in rats with and without cerebral ischemia. Am J Chin Med. 2006, 34 (2): 351-361. 10.1142/S0192415X06003886.View ArticlePubMedGoogle Scholar
- Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science. 1997, 277 (5322): 55-60. 10.1126/science.277.5322.55.View ArticlePubMedGoogle Scholar
- Yuan HT, Khankin EV, Karumanchi SA, Parikh SM: Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol. 2009, 29 (8): 2011-2022. 10.1128/MCB.01472-08.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhang ZG, Zhang L, Croll SD, Chopp M: Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience. 2002, 113 (3): 683-687. 10.1016/S0306-4522(02)00175-6.View ArticlePubMedGoogle Scholar
- Xi G, Keep RF, Hoff JT: Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006, 5 (1): 53-63. 10.1016/S1474-4422(05)70283-0.View ArticlePubMedGoogle Scholar
- Yang S, Chen Y, Deng X, Jiang W, Li B, Fu Z, Du M, Ding R: Hemoglobin-Induced Nitric Oxide Synthase Overexpression and Nitric Oxide Production Contribute to Blood–brain Barrier Disruption in the Rat. J Mol Neurosci. 2013, in pressGoogle Scholar
- Fan F, Stoeltzing O, Liu W, McCarty MF, Jung YD, Reinmuth N, Ellis LM: Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells. Cancer Res. 2004, 64 (9): 3186-3190. 10.1158/0008-5472.CAN-03-0407.View ArticlePubMedGoogle Scholar
- Hangai M, He S, Hoffmann S, Lim JI, Ryan SJ, Hinton DR: Sequential induction of angiogenic growth factors by TNF-alpha in choroidal endothelial cells. J Neuroimmunol. 2006, 171 (1–2): 45-56.View ArticlePubMedGoogle Scholar
- Scott BB, Zaratin PF, Gilmartin AG, Hansbury MJ, Colombo A, Belpasso C, Winkler JD, Jackson JR: TNF-alpha modulates angiopoietin-1 expression in rheumatoid synovial fibroblasts via the NF-kappa B signalling pathway. Biochem Biophys Res Commun. 2005, 328 (2): 409-414. 10.1016/j.bbrc.2004.12.180.View ArticlePubMedGoogle Scholar
- Krikun G, Schatz F, Finlay T, Kadner S, Mesia A, Gerrets R, Lockwood CJ: Expression of angiopoietin-2 by human endometrial endothelial cells: regulation by hypoxia and inflammation. Biochem Biophys Res Commun. 2000, 275 (1): 159-163. 10.1006/bbrc.2000.3277.View ArticlePubMedGoogle Scholar
- Hsiao SH, Tsai LJ: A neurovascular transmission model for acupuncture-induced nitric oxide. J Acupunct Meridian Stud. 2008, 1 (1): 42-50. 10.1016/S2005-2901(09)60006-6.View ArticlePubMedGoogle Scholar
- Lan L, Tao J, Chen A, Xie G, Huang J, Lin J, Peng J, Chen L: Electroacupuncture exerts anti-inflammatory effects in cerebral ischemia-reperfusion injured rats via suppression of the TLR4/NF-kappaB pathway. Int J Mol Med. 2013, 31 (1): 75-80.PubMedGoogle Scholar
- Lee ST, Chu K, Sinn DI, Jung KH, Kim EH, Kim SJ, Kim JM, Ko SY, Kim M, Roh JK: Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem. 2006, 96 (6): 1728-1739. 10.1111/j.1471-4159.2006.03697.x.View ArticlePubMedGoogle Scholar
- Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, Stewart DJ: Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol. 2003, 162 (6): 1927-1936. 10.1016/S0002-9440(10)64326-X.View ArticlePubMedPubMed CentralGoogle Scholar
- Pan P, Zhang X, Qian H, Shi W, Wang J, Bo Y, Li W: Effects of electro-acupuncture on endothelium-derived endothelin-1 and endothelial nitric oxide synthase of rats with hypoxia-induced pulmonary hypertension. Exp Biol Med (Maywood). 2010, 235 (5): 642-648. 10.1258/ebm.2010.009353.View ArticleGoogle Scholar
- Qutub AA, Mac Gabhann F, Karagiannis ED, Vempati P, Popel AS: Multiscale models of angiogenesis. IEEE Eng Med Biol Mag. 2009, 28 (2): 14-31.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/127/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.